Lactoferrin and SIBO: What the Evidence Actually Shows

There are no clinical trials testing lactoferrin as a treatment for small intestinal bacterial overgrowth. If you have seen lactoferrin mentioned alongside SIBO, it is almost certainly because of something different: lactoferrin is used as a marker in stool testing, not as a therapy.

We sell lactoferrin, and we are telling you there is no trial evidence here. That is more useful than the alternative. This article summarises published research and is not medical advice.

Why lactoferrin comes up in SIBO discussions at all

Lactoferrin is released by neutrophils, the white blood cells that arrive first at a site of inflammation. When there is inflammation in the gut, neutrophils migrate into the intestinal lining and lactoferrin ends up in stool.

That makes faecal lactoferrin a laboratory marker of intestinal inflammation, used alongside faecal calprotectin. It is measured, not administered. Some studies have looked at whether SIBO raises faecal lactoferrin, with mixed and inconsistent results.

So when lactoferrin appears in a SIBO article or test panel, it is usually in that diagnostic sense. It is an easy thing to misread as a treatment.

What SIBO treatment evidence actually covers

The treatments with published evidence are antibiotics, most frequently rifaximin, with some research into herbal antimicrobial protocols and specific probiotic combinations. SIBO is diagnosed with breath testing and managed by a clinician. It is not something to self-treat with a supplement.

Is there any relevant lactoferrin research?

Adjacent, yes. Directly on SIBO, no. What exists:

• Human trials show lactoferrin supports beneficial gut taxa including Bifidobacterium and Lactobacillus, and affects short-chain fatty acid production.
• Its iron-binding activity limits free iron, which most bacteria need to grow, while bifidobacteria have low iron requirements. That is a selective effect on microbial balance rather than broad suppression.
• Laboratory work shows effects on the intestinal barrier under inflammatory stress.

None of that was studied in people with diagnosed SIBO, and general microbiome effects cannot be assumed to apply to bacterial overgrowth in the small intestine, which is a distinct problem in a distinct location.

The practical answer

If you think you have SIBO, see a doctor and get tested. If you already have a diagnosis and are considering lactoferrin alongside your treatment, discuss it with the clinician managing your care, and understand that you would be going beyond the published evidence.

For what lactoferrin has actually been shown to do in the gut, see our gut and microbiome research summary.

Related reading

• Lactoferrin and the intestinal barrier
• Lactoferrin for gut health
• The full research review, graded by evidence strength

This information summarises published research and is provided for education. It is not medical advice and not a claim about the effects of any Lactoferrin Co. product. Contains milk. Always consult a qualified healthcare professional about diagnosis and treatment.